MedTrace Logo

Bioequivalence Study of Naproxen Sodium 550 mg Tablets Under Fasting Condition

NCT01052129 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 26

Last updated 2010-05-27

No results posted yet for this study

Summary

An open label randomised, two-treatment, two-period, two-sequence, single-dose, crossover, comparative bioequivalence study.

Conditions

  • Healthy

Interventions

DRUG

Naproxen sodium

Naproxen Sodium Tablets 550 mg

Sponsors & Collaborators

  • Dr. Reddy's Laboratories Limited

    lead INDUSTRY

Principal Investigators

  • Dr. Umesh Dhakate, MBBS · Wellquest Clinical Research

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-05-31
Primary Completion
2006-05-31
Completion
2006-05-31

Countries

  • India

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01052129 on ClinicalTrials.gov